NCT06359067
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Assistance Publique - Hôpitaux de Paris (AP-HP) Paris, IDF, France
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
2,610 public trials
494 recruiting studies
Multiple Myeloma trial results
NCT03848845
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- GSK Investigational Site Atlanta, Georgia, United States
- GSK Investigational Site Indianapolis, Indiana, United States
- GSK Investigational Site Charlotte, North Carolina, United States
- GSK Investigational Site Madison, Wisconsin, United States
Completed
Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide
NCT06069024
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +16 more
- Locations
-
- the First Affiliated Hospital of Shandong First Medical University Jinan, Shandong, China
NCT05306587
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Odense University Hospital Odense, Denmark
Completed
Bone Healing During Ninlaro Exposure
NCT04028115
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Odense University Hospital Odense, Denmark
NCT01588015
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +198 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Completed
Isatuximab Single Agent Study in Japanese Relapsed AND Refractory Multiple Myeloma Patients
NCT02812706
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Investigational Site Number :392001 Nagoya, Aichi-ken, Japan
- Investigational Site Number :392005 Shibukawa-shi, Gunma, Japan
- Investigational Site Number :392010 Hiroshima, Japan
- Investigational Site Number :392015 Kanazawa, Ishikawa-ken, Japan
Completed
Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment
NCT03450057
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- General Hospital of Athens "Alexandra" Athens, Attica, Greece
NCT02891811
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Medizinische Universitaet Graz, Univ.-Klinik f. Innere Medizin, Onkologie Graz, Austria
- Med. Universität Innsbruck, Univ.-Klinik f. Innere Medizin V, Hämatologie u. Onkologie Innsbruck, Austria
- Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik Kufstein, Austria
- LKH Hochsteiermark - Standort Leoben Abteilung für Innere Medizin und Hämatologie und internistische Onkologie Leoben, Austria
NCT02119468
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Mayo Clinic Scottsdale, Arizona, United States
- City of Hope Medical Center Duarte, California, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Mayo Clinic Rochester, Minnesota, United States